by Legal Desire

27 November 2023

Hogan Lovells advises Fresenius Kabi on divestment of Halden plant in Norway

M&A Healthcare & Life Sciences Completed Norway

Advising firms

Hogan Lovells Cadwalader

Sell-side acting for Fresenius Kabi AG

Deal team

17 lawyers named

Lawyer	Firm	Seniority	Practice	Office
Torsten Rosenboom Lead	Hogan Lovells Cadwalader	Partner	Corporate/ M&A	Frankfurt
Dr Christoph Naumann	Hogan Lovells Cadwalader	Partner	Corporate/ M&A	Not stated
Andreas Thun	Hogan Lovells Cadwalader	Counsel	Corporate/ M&A	Not stated
Dr Marius Rothermund	Hogan Lovells Cadwalader	Senior associate	Corporate/ M&A	Not stated
Matthias Murr	Hogan Lovells Cadwalader	Senior associate	Corporate/ M&A	Not stated
Dr Mike Karl Schmidt	Hogan Lovells Cadwalader	Associate	Corporate/ M&A	Not stated
Hannah Wohlfarth	Hogan Lovells Cadwalader	Associate	Corporate/ M&A	Not stated
Nicolas Persch	Hogan Lovells Cadwalader	Other	Corporate/ M&A	Not stated
Melisa Gürsoy	Hogan Lovells Cadwalader	Other	Corporate/ M&A	Not stated
Bianca Engelmann	Hogan Lovells Cadwalader	Partner	Finance	Not stated
Arne Thiermann	Hogan Lovells Cadwalader	Partner	Life Sciences	Not stated
Dr Benjamin Goehl	Hogan Lovells Cadwalader	Senior associate	Life Sciences	Not stated
Marcus Kaiser	Hogan Lovells Cadwalader	Senior associate	Life Sciences	Not stated
Caroline Schmalenbach	Hogan Lovells Cadwalader	Associate	Life Sciences	Not stated
Dr. Marc Schweda	Hogan Lovells Cadwalader	Partner	Antitrust	Not stated
Dr Jan-Christoph Rudowicz	Hogan Lovells Cadwalader	Counsel	Antitrust	Not stated
Dr Sabrina Gäbeler	Hogan Lovells Cadwalader	Counsel	Employment	Not stated

14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value: Not stated
What the figure measures: Not stated
Client: Fresenius Kabi AG
Counterparties: HP Halden Pharma AS (Buy-side)
Prange Group (Buy-side)